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Abstract
Background: Older people with hypertension and multiple chronic conditions (MCC) receive complex treatments
and face challenging trade-offs. Patients’ preferences for different health outcomes can impact multiple treatment
decisions. Since evidence about outcome preferences is especially scarce among people with MCC our aim was to
elicit preferences of people with MCC for outcomes related to hypertension, and to determine how these
outcomes should be weighed when benefits and harms are assessed for patient-centered clinical practice
guidelines and health economic assessments.
Methods: We sent a best-worst scaling preference survey to a random sample identified from a primary care
network of Kaiser Permanente (Colorado, USA). The sample included individuals age 60 or greater with
hypertension and at least two other chronic conditions. We assessed average ranking of patient-important
outcomes using conditional logit regression (stroke, heart attack, heart failure, dialysis, cognitive impairment, chronic
kidney disease, acute kidney injury, fainting, injurious falls, low blood pressure with dizziness, treatment burden) and
studied variation across individuals.
Results: Of 450 invited participants, 217 (48%) completed the survey, and we excluded 10 respondents who had
more than two missing choices, resulting in a final sample of 207 respondents. Participants ranked stroke as the
most worrisome outcome and treatment burden as the least worrisome outcome (conditional logit parameters:
3.19 (standard error 0.09) for stroke, 0 for treatment burden). None of the outcomes were always chosen as the
most or least worrisome by more than 25% of respondents, indicating that all outcomes were somewhat
worrisome to respondents. Predefined subgroup analyses according to age, self-reported life-expectancy, degree of
comorbidity, number of medications and antihypertensive treatment did not reveal meaningful differences.
Conclusions: Although some outcomes were more worrisome to patients than others, our results indicate that
none of the outcomes should be disregarded for clinical practice guidelines and health economic assessments.
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Background
In older people with multiple chronic conditions (MCC)
treatment is often complex and burdensome [1]. When
considering prevention of cardiovascular disease in older
people with MCC and hypertension, there is a trade-off
between prioritizing treatments to achieve long-term
goals, and avoiding treatment burden and side effects.
This trade-off usually depends on the individual’s health
profile and preferences.
A previous study involving patients and caregivers
identified the question of how intensively to lower
blood pressure in people with MCC as a top priority
question to answer [2]. However, empiric evidence on
preferences of people with MCC for patient-important
outcomes related to hypertension to inform this ques-
tion is lacking. This evidence is crucial, because how a
patient values different health outcomes related to
hypertension will determine the trade-off of whether
to start or intensify antihypertensive treatment [3],
and also related questions such as which medication
to add. Evidence about patient preferences is essential
to inform population-level decisions, such as clinical
practice guidelines and health economic assessments,
in a patient-centered manner [4]. For example, defin-
ing the relative importance of outcomes is critical in
the development of clinical practice guidelines [5–7],
and weighing outcomes differently (relative to one an-
other) can shift the benefit-harm balance of an inter-
vention [8]. Patient preferences can be considered
quantitatively in guideline development to weigh ben-
efits against harms [9].
While some studies have elicited patients’ preferences
on benefits and harms related to hypertension treatment,
they considered only a few of the possible outcomes or
they combined outcomes, and did not recruit or report
on people with MCC [10–13].
Therefore, our primary aim was to utilize best-worst
scaling to elicit preferences about patient-important out-
comes related to hypertension in people with MCC, in
order to determine the relative importance that should
be attributed to these outcomes in guideline development
or policy-making. Our second aim was to explore whether
preferences were associated with baseline characteristics.
Methods
Study design and setting
We conducted a cross-sectional survey to elicit preferences
for outcomes related to the treatment of hypertension in in-
dividuals with MCC and hypertension. Participants were
members of Kaiser Permanente Colorado, a not-for-profit
integrated delivery system. Both the Institutional Re-
view Boards of Johns Hopkins University and Kaiser
Permanente Colorado approved this study.
Eligibility
Using clinical and administrative data derived from the
electronic health record and membership enrollment files,
we identified individuals who were 60 years of age or
older, had a history of hypertension, had one or more
non-cardiovascular comorbidities, and had a score of 3 or
more based on the Quan adaptation of the Elixhauser co-
morbidity index (Quan score) [14]. Non-cardiovascular
comorbidities we considered were HIV/AIDS, alcohol
abuse, anemia, chronic pulmonary disease, depression, de-
mentia, drug abuse, liver disease, neurological disorders
and other paralyses, cirrhosis, osteoarthritis, osteoporosis,
peptic ulcer disease, psychoses, pulmonary/circulation dis-
orders, renal failure and rheumatoid arthritis.
We excluded patients who were not fluent in spoken
English and patients who were visually impaired (e.g.,
legal blindness). We included patients who were mildly
cognitively impaired, but excluded people who had a
diagnosis of dementia within the 365 days prior to the
cohort creation.
Sample recruitment
A random sample of eligible individuals was identified
administratively using the Kaiser Permanente Colorado
Virtual Data Warehouse, a quality-controlled common
data model derived from multiple Kaiser Permanente
Colorado data sources [15]. We recruited random sam-
ples of eligible participants in waves of 50 until we
reached the target of 200 completed surveys. Potential
participants received a recruitment mailing that included
an invitation letter, a Study Information Sheet, an opt-
out postcard, the paper survey with a postage paid re-
turn envelope, and a $10 gift card incentive. Potential
participants received follow-up telephone calls after 2 to
4 weeks which served as reminders and also offers of as-
sistance with survey completion if needed.
There is no sample size calculation for best-worst scal-
ing [16, 17]. In a review of best-worst scaling surveys in
health care [17], the median sample size among object
case surveys was 180. We defined a target sample size of
200.
Development of the best-worst scaling survey
We designed the survey as best-worst scaling tasks (case
1), a method introduced by Finn and Louviere [18]. In
this design, respondents are asked to choose the best
and the worst of three or more “objects”. The main ad-
vantage of this method is that it has more discrimination
than for example discrete choice experiments, as it also
elicits which is the worst object, and not only which is
the best. Thereby, it can yield complete rather than
partial ranking information [17]. Best-worst scaling is as-
sumed to decrease cognitive burden placed on respon-
dents, by asking to compare only a few of the outcomes
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at a time, instead of comparing all at once. We chose this
method to minimize the cognitive burden, since we also
included respondents with mild cognitive impairment,
and because it allowed us to compare many outcomes.
We used the balanced incomplete block design (generated
using SAS version 9.4); the survey consisted of 11 blocks
of five outcomes in total. As all outcomes had a negative
impact on health, we phrased the question as: “If one of
the following health problems were to happen to you,
which would worry you most and which would worry you
least?” The survey is shown in Additional file 1.
Based on previous input from patient and caregiver
focus groups [2] and a literature review of outcomes that
have been used in relevant clinical trials, we identified
12 patient-important outcomes (death, myocardial in-
farction, stroke, chronic heart failure, end-stage renal
disease (with dialysis), chronic kidney disease, acute kid-
ney injury, hypotension with dizziness, syncope, cogni-
tive impairment, injurious falls and treatment burden).
We included all except death in the survey. Based on an-
other study [19], we assumed that death would almost
always be considered the most worrisome outcome. We
described symptomatic outcomes in lay language with
expected severities based on input from clinicians and
our patient and caregiver co-investigators. We described
expected severities in order to decrease cognitive bur-
den, so respondents would not need to consider prob-
abilities. For example, we chose a mild scenario of a
myocardial infarction, a mild to moderate scenario for
stroke, and a severe scenario for chronic kidney disease
(outcome descriptions in Additional file 1). We did not
specify which outcomes were side effects from medica-
tions and which were outcomes related to hypertension.
Researchers at Johns Hopkins University pilot tested
the questionnaires with our patient and caregiver co-
investigators in order to assess whether the instructions,
the descriptions of outcomes and the best-worst scaling
tasks were clear and understandable.
Data collection on respondent characteristics
We asked about selected respondent characteristics that
could not be reliably drawn from their medical records
and that we thought might influence their preferences.
We abstracted information on specific conditions from
the Kaiser Permanente Virtual Data Warehouse (defini-
tions listed in Additional file 2: Table S1), and calculated
an updated Quan score [14] for the time from Septem-
ber 2014 to August 2016.
Analysis
All analyses were preplanned and performed using R
version 3.3.1 unless stated otherwise. Best-worst scaling
surveys can be analyzed in several ways [17, 20], there-
fore we used three different analyses in order to suggest
how to weigh different outcomes related to hypertension.
The main analysis was conditional logit regression, because
this is based in random utility theory and therefore real-
world choice behaviour [17] and can be used to calculate
utilities based on econometric models [21] (although utility
is sometimes only used to refer to preference elicitation
under uncertainty). In sensitivity analyses, we compared
this to mean best-minus-worst scores and surface under
the cumulative ranking curve (SUCRA) scores. Best-minus-
worst scores are simple count scores and can be calculated
for each individual – thus, they also lend themselves to ex-
plore variability and potential associations with baseline
characteristics. SUCRA scores are interesting because they
have a natural scale from 0 to 1 and can be therefore readily
used as weights, for example in quantitative benefit-harm
assessments [22, 23]. Furthermore, because both the mean
best-minus-worst scores and the SUCRA scores lie in a
closed range (but conditional logit parameters can be infin-
ite), their minimum and maximum scores can indicate
whether an outcome is not worrisome (i.e. most respon-
dents choose the outcome always as least worrisome) or
whether an outcome dominates (i.e. most respondents
choose the outcome always as most worrisome).
In the conditional logit regression, the model outcome
was defined as − 1 if it was the most worrisome outcome
and + 1 if it was the least worrisome outcome, with
strata defined by respondent and block. We set the least
worrisome outcome as a reference so that all conditional
logit coefficients were positive relative to the reference,
with higher values indicating more worrisome outcomes.
Best-minus-worst scores count how many times an
outcome was selected as best (least worrisome) or worst
(most worrisome), averaged across respondents. The
range of scores was − 5 to 5, as each outcome appeared
in five of eleven blocks.
We calculated SUCRA scores using STATA version
13.1 based on estimated mean differences of the best-
minus-worst scores between outcomes using a network
meta-analysis model. The cumulative ranking curve of
each outcome describes the probability an outcome has
a certain rank or a higher one. If an outcome was always
ranked as the least worrisome, it would receive a SUCRA
score of 0, if it was always ranked as the most worri-
some, it would receive a score of 1. The analysis is
analogous to a network meta-analysis: Each block repre-
sents a trial, and each outcome in a block represents a
treatment arm. The methodology was originally devel-
oped to rank treatments in a network meta-analysis of
clinical trials [24]. The SUCRA analysis considered only
the best-minus-worst scores of outcomes that were
chosen as least or most worrisome [22]. As not choosing
an outcome is also informative about the rank, the ana-
lysis could be considered as less powered than the other
scores. While SUCRA scores directly reflect differences
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in the probability of choosing an outcome, conditional
logit parameters need to be transformed for this pur-
pose [17, 21].
To assess the variability in the preferences, we calcu-
lated individual best-minus-worst scores. Furthermore,
to explore potential associations of preferences with
baseline characteristics, we performed pre-planned (hy-
pothesis-driven) subgroup analyses and (preference data-
driven) hierarchical cluster analysis. Subgroup analyses
were according to age, current antihypertensive treatment
(yes/no), Quan adaptation of Elixhauser comorbidity
index [14], self-reported number of pills per day, and self-
reported life-expectancy stratified by age. We performed
hierarchical cluster analysis using a variant of Ward’s
minimum variance criterion that uses Euclidean distances
[25]. This kind of cluster analysis defines clusters such
that the variance of choices within the clusters of respon-
dents is minimized – i.e. respondents within a cluster gave
similar answers. We selected the number of clusters such
that at least 25 respondents were included in each cluster.
We excluded respondents with more than two missing
or invalid choices. The answer to each block counted as
two choices (least and most worrisome). We counted
choices as invalid if people chose more than one out-
come as least or most worrisome or if they chose the
same outcome as most and least worrisome. We counted
choices as missing if people did not choose a least or
most worrisome outcome.
Sometimes the other choices a respondent made in-
dicated a consistent ranking that allowed us to assign
the missing choice. If no such ranking could be de-
duced, or if the choices were inconsistent (for example
outcome A is more worrisome than B, B more worri-
some than C, and C more worrisome than A), the
choice was assigned according to what the respondent
with the most similar choices had selected.
In order to investigate whether the survey was well
understood, we analyzed overall consistency of the re-
spondents’ answers by calculating a measure of variance
in best-minus-worst scores, namely the sum of the
squares of each score, per respondent across outcomes
[20]. The higher the variance, the more consistent the
answer: If respondents answered with full consistency,
one outcome had a score of − 5, and another had a score
of + 5. Other outcomes had scores between − 3 and 3. If,
however, respondents were not sure about how the out-
comes should be ranked, the outcomes had more similar
scores. Accordingly, the variance of the scores was
higher if the outcomes were ranked consistently, than if
they were not. The analysis of consistency considered
only respondents without missing or invalid choices, as
the way we replaced missing choices was expected to
increase consistency. Inconsistent answers could imply
either that the survey was not fully understood, or else,
that the respondent perceived outcomes to be similarly
worrisome. Typically, skewed distributions are observed
from best-worst scaling tasks which are consistent with
a gamma or a log-normal distribution – thus, most re-
spondents answer with high consistency [20].
Results
Respondent characteristics
Figure 1 shows the flow of respondents and non-
respondents. We received 217 (out of 450) completed
surveys (response rate of 48%). 192 responses were
complete, and 15 were complete except for one or two
missing choices. We excluded 10 respondents who had
more than two missing choices (8 of 10 had 16 to 22 out
of 22 choices missing, 1 had 3 and 1 had 4 missing
choices), yielding a total analytic sample of 207.
Most respondents answered with high consistency
(Additional file 3: Figure S1). Respondents were similar to
Fig. 1 Study flow of respondents and non-respondents
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non-respondents in terms of age, Quan score, gender dis-
tribution, race and ethnicity (Additional file 3: Table S2).
Characteristics of respondents are shown in Table 1 and
Table 2. Respondents were between 60 and 97 years old,
mostly non-hispanic and white, and women and men were
approximately equally represented. The most frequent
conditions additionally to hypertension were hyperlipid-
emia, chronic kidney disease (stage 3 or higher) and dia-
betes (type II). While all respondents were hypertensive,
only 76.5% were prescribed antihypertensives.
Conditional logit parameters, mean best-minus-worst
scores and SUCRA scores were all similar when excluding
respondents who had one or two missing choices (n = 15)
as when including them (Additional file 3: Table S3).
Ranking of outcomes in the study population
In the main analysis (conditional logit regression), stroke
was ranked as the most worrisome outcome, followed by
heart attack and heart failure (Table 3). The least worri-
some outcome was treatment burden. In sensitivity ana-
lyses using mean best-minus-worst scores and SUCRA
scores, ranking of outcomes was similar, but not com-
pletely identical. Across all analyses, stroke was always
ranked as the most worrisome outcome; heart attack
and heart failure were always the second or third most
Table 1 Baseline characteristics of survey respondents extracted
from medical records of all 217 respondents
Mean age (SD) [range] 74.5 (8.4) [60,97]
Females (%) 49.8
Race (%)
Asian 1.8
Black/African American 3.7
White 84.8
Hawaiian/Pacific Islander 0
Native American 0
Multiple 0.5
Other 5.1
Unknown 4.1
Ethnicity (%)
Hispanic 7.8
Non-hispanic 91.2
Unknown 0.9
Medical history (%)
Hypertension 100
Hyperlipidemia 81.1
Diabetes mellitus type 2 41.0
Chronic kidney disease 49.8
Mild cognitive impairment 12.4
Stroke 3.2
Myocardial infarction 12.0
Congestive heart failure 15.7
Depression 32.3
Mean Total Quan Score (SD) [range] 6.1 (2.7) [3, 16]
Antihypertensives (%) 76.5
Antihyperglycemics (%) 24.4
Lipid lowering medications (%) 55.8
Smoking status (%)
Current 6.0
Former 47.0
Never 47.0
Mean BMI (SD) 29.4 (6.2)
Chronic kidney disease was defined as stage 3 or higher, excluding end-stage
renal disease. Diagnoses are listed in Additional file 2
Table 2 Self-reported baseline characteristics of survey
respondents of all 217 respondents
Living alone (%) 25.8
Had an injurious fall in the past 12 months (%) 26.3
Has experienced low blood pressure with dizziness (%) 22.1
Has experienced passing out or fainting (%) 12.0
Currently receives dialysis (%) 1.4
Age at first treatment for high blood pressure? (%)
30 or younger 7.4
31–45 13.8
46–60 30.9
61–75 17.5
Older than 75 5.1
Never / not anymore 6.5
Missing 18.9
Unsure 18.0
Number of pills per day currently taken (%)
Less than 4 31.8
4–7 33.2
8–11 16.6
12–15 10.1
16–19 3.2
More than 19 3.2
Self-reported life-expectancy to age range (%)
65–70 1.8
70–75 5.5
75–80 11.1
80–85 23.0
85–90 33.6
90 or older 24.9
For age at first high blood pressure treatment, many respondents wrote a
question mark next to the age, summarized as “unsure”. Self-reported life-
expectancy should be interpreted bearing in mind that many respondents
were already older than the lowest proposed category
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worrisome outcome; and low blood pressure with dizzi-
ness, fainting, injurious falls and treatment burden were
ranked as the four least worrisome outcomes. The mean
values and standard errors (Table 3) imply that while
some outcomes were more worrisome than others with
statistical significance, some outcomes were not ranked
differently: for example, heart attack and heart failure
were similarly worrisome in all analyses.
Mean best-minus-worst scores across the study popu-
lation roughly lied in the middle half of the scale, indi-
cating that all outcomes were somewhat worrisome, and
no outcome completely dominated, i.e. no outcome was
always chosen as the most worrisome. SUCRA scores
showed similar results. While here, stroke was the most
worrisome outcome across the population, with a
SUCRA score close to the maximum of the scale, the
least worrisome outcome, in this case low blood pres-
sure with dizziness, was not as close to the minimum of
the scale.
Variability of preferences between individuals
The range of individual best-minus-worst scores was
wide (Fig. 2). In the interquartile range (IQR) for stroke,
a best-minus-worst score of − 5 was not included (only
21% of the respondents always chose stroke as the most
worrisome outcome). Similarly, only 18% of the respon-
dents always chose treatment burden as the least worri-
some outcome, and thus the IQR did not include 5,
indicating that none of the outcomes was not worrisome
in this population. While some respondents found treat-
ment burden only a little or not worrisome, others found
it more worrisome than other outcomes.
In subgroup analyses according to age, life-expectancy,
number of pills per day, taking antihypertensives, and
Quan score, differences in preferences were only small
and not meaningful (Additional file 3: Figures S2–S6).
Cluster analysis identified groups of respondents who
made similar choices, and scored outcomes more simi-
larly, with smaller ranges compared to Fig. 2. Different
patterns were apparent (Fig. 3): The largest cluster (cluster
1, n = 66 / 32%) worried most about stroke, and worried
more about end-stage renal disease than respondents in
other clusters. Respondents of cluster 2 (n = 35 / 17%)
worried most about cognitive impairment. Respondents of
cluster 3 (n = 49 / 24%) worried most about heart failure,
and those of cluster 4 (n = 31 / 15%) about stroke. Respon-
dents of cluster 5 (n = 26 / 13%) worried less about kidney
outcomes than other respondents, and more about treat-
ment burden. Differences in baseline characteristics be-
tween clusters are shown in Additional file 3: Table S4.
Discussion
Our survey showed that people with MCC and hyper-
tension perceived stroke as the most worrisome out-
come and treatment burden, low blood pressure with
dizziness, injurious falls and fainting as least worrisome
outcomes. Although we found differences between pref-
erences for the eleven outcomes, our analyses indicated
that the less worrisome outcomes remained relevant
outcomes nevertheless. Thus, all outcomes included in
this survey should be considered in population-level de-
cisions, such as guideline development and health eco-
nomic assessments, concerning people with multiple
chronic conditions and hypertension, and our results
Table 3 Ranking of outcomes in the study population
Main analysis Sensitivity analysis 1 Sensitivity analysis2
Conditional logit parameters Best-minus-worst scores SUCRA scores
Outcomes Mean SE Mean SE Mean SE
Stroke 3.19 0.09 −2.63 0.12 0.989 0.002
Heart attack 2.75 0.09 −1.91 0.13 0.800 0.014
Heart failure 2.73 0.09 −2.04 0.13 0.800 0.010
End stage renal disease (Dialysis) 1.95 0.09 −0.68 0.15 0.571 0.014
Cognitive impairment 1.92 0.09 −0.54 0.15 0.562 0.003
Chronic kidney disease 1.87 0.08 −0.60 0.10 0.664 0.009
Acute kidney injury 1.38 0.08 0.07 0.08 0.434 0.017
Fainting 0.44 0.08 1.63 0.11 0.117 0.016
Injurious fall 0.09 0.08 2.16 0.14 0.232 0.015
Low blood pressure with dizziness 0.06 0.08 2.18 0.11 0.08 0.03
Treatment burden 0a 2.35 0.14 0.253 0.007
Parameters from conditional logit regression (on log scale) with treatment burden as a reference (main analysis), mean best-minus-worst scores with a possible
range of [−5,5] (sensitivity analysis 1), SUCRA scores with a possible range of [0,1] (sensitivity analysis 2).
aTreatment burden was chosen as the reference, as it was the least worrisome outcome, so all parameters would be positive
SE Standard error, SUCRA Surface under the cumulative ranking curve
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could be used to define weights to balance benefits
against harms of interventions.
While outcomes related to hypertension were on aver-
age considered more worrisome than adverse events re-
lated to antihypertensive therapy, our results imply that
the difference in relative importance of the outcomes is
not very large, and that the least worrisome outcomes
were at least somewhat worrisome and should not be
neglected for decision-making.
We found that while preferences varied between indi-
viduals, certain patterns could be identified using cluster
analysis. For example, some patients were more worried
about cognitive impairment than others. Differences in
baseline characteristics between clusters were not con-
clusive. When cluster analyses do not identify specific
patient groups, their value may be limited. However, the
cluster analyses suggested common patterns of prefer-
ences that highlight the importance of decision-making:
Clinicians should be aware that there are different pat-
terns of preferences, but as they could not be attributed
to specific baseline characteristics, discussing the prefer-
ences and goals with the patient is crucial.
Our subgroup analyses did not indicate associations
with age, self-reported life-expectancy, antihypertensive
treatment, number of medications and number of condi-
tions (Quan score), but they may have been insufficiently
powered. While one study found that older people were
less willing to take an additional antihypertensive drug
[11], another study did not find associations with age,
nor with educational level, cognitive function, functional
autonomy, information-seeking or decision-making pref-
erences [13].
For a valid preference elicitation, it is crucial that the
instrument is well understood by the study population
[6], which may be challenging in older adults, especially
when mild cognitive impairment is prevalent. The best-
Fig. 2 Tukey boxplot of individual best-minus-worst scores of individual respondents. Outliers are shown as circles
Fig. 3 Cluster analysis of individual best-minus-worst scores. Tukey boxplots of best-minus-worst scores of individual respondents split into
clusters with smaller within-cluster variance. Outliers are not shown for better readability. The number of the plot corresponds to the numbering
of the clusters
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worst scaling survey was well understood, since there were
few missing answers and there was high consistency. In
comparison, in other, more complex hypertension prefer-
ence surveys, 20–30% were unable to decide which re-
sponse to choose [13]. A standard gamble exercise (where
respondents have to choose between a “sure option” of a
certain health state for a defined time and a “gamble op-
tion” with a defined probability of perfect health or imme-
diate painless death) was perceived as more difficult as the
health state became worse, and some found it frustrating
[10]. While our response rate of 48% was relatively high
considering the target population, it is possible that there
could be a response bias, although comparisons between
respondents and non-respondents did not show signifi-
cant differences in age, sex, race, ethnicity and Quan
score. We conclude that best-worst scaling is a more ap-
propriate, feasible method for eliciting preferences in older
people with MCC.
We performed the survey specifically in people with
MCC, because treatment decisions and guideline devel-
opment are much more challenging in this population,
and less information exists about preferences for people
with MCC. Age was shown to influence preference in
one study [11], and age correlates with the prevalence of
MCC. It is important to elicit preferences directly in the
target population [6], i.e. preferences may be different in
people without MCC. Guideline developers from the
Kaiser Permanente National Hypertension Guideline De-
velopment Team who answered the same survey worried
less about treatment burden (Additional file 3: Figure
S7), confirming the importance of eliciting patient pref-
erences. The Kaiser Permanente Colorado member
population of individuals over age 65 largely reflects the
demographics of the Denver Metropolitan Area, and has
a similar burden of MCC as elsewhere in the US. As
preference surveys across different cultures have shown
little variation when cost was not included [22, 26], the
outcome preferences elicited in this survey may also
apply to other populations of older people with MCC
and hypertension.
Our results must be interpreted in the light of the fact
that we did not include death as an outcome. Based on an-
other study, we assumed that death would almost always
be considered the worst outcome [19]. Thus, including
death would have led to eliciting much less information
about which are the most worrisome outcomes after
death.
Conclusions
This is the first study to elicit preferences for patient-
important outcomes related to hypertension among older
people with MCC. The results of this study may inform
population-level decisions, such as clinical practice guide-
lines and health economic assessments, performed for
older adults with hypertension and MCC. The range of
patient preferences we observed indicates that even
though stroke was the most worrisome outcome, all these
outcomes are important to people with multiple chronic
conditions and should be considered in population-level
decisions.
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